These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 15807179

  • 21. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density of the femoral neck in elderly Japanese women.
    Yamada Y, Ando F, Niino N, Ohta S, Shimokata H.
    J Mol Med (Berl); 2002 Jul; 80(7):452-60. PubMed ID: 12110951
    [Abstract] [Full Text] [Related]

  • 22. [A randomised clinical trial to study the effects of raloxifene hydrochloride on bone mineral density, biochemical markers of bone metabolism and serum lipids in postmenopausal women].
    Zheng SR, Wu YY, Zhang ZL, Yang X, Hui Y, Zhang Y, Chen SL, Den WH, Liu H, Ekangaki A, Stocks J, Harper K, Liu JL.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):226-9. PubMed ID: 12885371
    [Abstract] [Full Text] [Related]

  • 23. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.
    Morita A, Iki M, Dohi Y, Ikeda Y, Kagamimori S, Kagawa Y, Matsuzaki T, Yoneshima H, Marumo F, JPOS Study Group.
    Int J Epidemiol; 2004 Oct; 33(5):979-88. PubMed ID: 15358739
    [Abstract] [Full Text] [Related]

  • 24. [Association of polymorphisms of vitamin D receptor gene start codon and 3'-end region with bone mineral density in postmenopausal women].
    Zhang ZL, Zhao JX, Meng XW, Zhou XY, Xing XP, Xia WB.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):5-8. PubMed ID: 12579489
    [Abstract] [Full Text] [Related]

  • 25. [Association of calcitonin receptor gene polymorphism with bone mineral density in Shanghai women].
    Zhao HY, Liu JM, Ning G, Zhang LZ, Jiang L, Dai M, Xu MY, Chen JL.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):258-61. PubMed ID: 12905735
    [Abstract] [Full Text] [Related]

  • 26. The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in post-menopausal women.
    Malacara JM, Pérez-Luque EL, Martínez-Garza S, Sánchez-Marín FJ.
    Maturitas; 2004 Oct 15; 49(2):163-9. PubMed ID: 15474761
    [Abstract] [Full Text] [Related]

  • 27. [Association of Xba I, Pvu II, and Bst U I polymorphisms of estrogen receptor-alpha gene with bone mass in men].
    Zhang ZL, Qin YJ, He JW, Huang QR, Hu YQ, Li M, Liu YJ, Zhang H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug 15; 22(4):447-9. PubMed ID: 16086289
    [Abstract] [Full Text] [Related]

  • 28. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in postmenopausal women: a randomized clinical trial in Beijing.
    Zheng S, Wu Y, Zhang Z, Yang X, Hui Y, Zhang Y, Chen S, Deng W, Liu H, Ekangaki A, Stocks J, Harper K, Liu J.
    Chin Med J (Engl); 2003 Aug 15; 116(8):1127-33. PubMed ID: 12935394
    [Abstract] [Full Text] [Related]

  • 29. Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women.
    Vandevyver C, Vanhoof J, Declerck K, Stinissen P, Vandervorst C, Michiels L, Cassiman JJ, Boonen S, Raus J, Geusens P.
    J Bone Miner Res; 1999 Sep 15; 14(9):1576-82. PubMed ID: 10469287
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women.
    Firat SC, Cetin Z, Samanci N, Aydin F, Balci N, Gungor F, Firat MZ, Luleci G, Karauzum SB.
    Maturitas; 2009 Aug 20; 63(4):352-6. PubMed ID: 19520527
    [Abstract] [Full Text] [Related]

  • 31. Raloxifene: results from the MORE study.
    Agnusdei D, Iori N.
    J Musculoskelet Neuronal Interact; 2000 Dec 20; 1(2):127-32. PubMed ID: 15758505
    [Abstract] [Full Text] [Related]

  • 32. Association of estrogen receptor alpha and collagen type I alpha 1 gene polymorphisms with bone mineral density in postmenopausal women.
    Erdogan MO, Yıldız H, Artan S, Solak M, Taşcıoğlu F, Dündar U, Eser B, Colak E.
    Osteoporos Int; 2011 Apr 20; 22(4):1219-25. PubMed ID: 20532479
    [Abstract] [Full Text] [Related]

  • 33. Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.
    Hernández E, Valera R, Alonzo E, Bajares-Lilue M, Carlini R, Capriles F, Martinis R, Bellorin-Font E, Weisinger JR.
    Kidney Int; 2003 Jun 20; 63(6):2269-74. PubMed ID: 12753317
    [Abstract] [Full Text] [Related]

  • 34. The association between postmenopausal vertebral bone mineral density and estrogen receptor gene alleles in ethnic Japanese living in western Japan.
    Ushiroyama T, Heishi M, Higashio S, Ikeda A, Ueki M.
    Res Commun Mol Pathol Pharmacol; 2001 Jul 20; 109(1-2):15-24. PubMed ID: 11458981
    [Abstract] [Full Text] [Related]

  • 35. [Study of the impact of candidate genes on bone mineral density in postmenopausal women].
    Zhao HY, Liu JM, Ning G, Zhang LZ, Song HD, Chen Y, Jiang L, Dai M, Xu MY, Chen JL.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec 20; 40(12):803-7. PubMed ID: 16412323
    [Abstract] [Full Text] [Related]

  • 36. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
    Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH.
    J Bone Miner Res; 2000 Dec 20; 15(12):2479-86. PubMed ID: 11127213
    [Abstract] [Full Text] [Related]

  • 37. Tofupill/Femarelle (DT56a): a new phyto-selective estrogen receptor modulator-like substance for the treatment of postmenopausal bone loss.
    Yoles I, Yogev Y, Frenkel Y, Nahum R, Hirsch M, Kaplan B.
    Menopause; 2003 Dec 20; 10(6):522-5. PubMed ID: 14627860
    [Abstract] [Full Text] [Related]

  • 38. Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study.
    Levy C, Harnois DM, Angulo P, Jorgensen R, Lindor KD.
    Liver Int; 2005 Feb 20; 25(1):117-21. PubMed ID: 15698408
    [Abstract] [Full Text] [Related]

  • 39. Estrogen receptor gene polymorphism, but not estradiol levels, is related to bone density in healthy adolescent boys: a cross-sectional and longitudinal study.
    Lorentzon M, Lorentzon R, Bäckström T, Nordström P.
    J Clin Endocrinol Metab; 1999 Dec 20; 84(12):4597-601. PubMed ID: 10599725
    [Abstract] [Full Text] [Related]

  • 40. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C, Dane B, Cetin A, Erginbas M.
    Gynecol Endocrinol; 2007 Jul 20; 23(7):398-403. PubMed ID: 17701771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.